lunes, 26 de abril de 2021

SARS-CoV-2 antibody response robust in nursing home residents after Pfizer-BioNTech vaccine

SARS-CoV-2 antibody response robust in nursing home residents after Pfizer-BioNTech vaccine

No hay comentarios:

Publicar un comentario